Synchronoss (SNCR) Registers a Bigger Fall Than the Market: Important Facts to Note

Synchronoss (SNCR) closed down 2.87% at $6.44, underperforming the broader market, despite having outperformed the S&P 500 in the period prior to this trading session. The company is expected to report a significant 219.23% year-over-year EPS increase to $0.31 for the upcoming quarter on steady revenue of $42.96 million, but full-year estimates project a substantial 37.42% decline in EPS to $1.02. Synchronoss currently holds a Zacks Rank of #4 (Sell) with stagnant recent analyst EPS projections, yet trades at a forward P/E of 6.5, a considerable discount to its Internet - Software industry average of 31.31, suggesting a mixed outlook ahead of its earnings report.

Analysis

Synchronoss (SNCR) presents a conflicted investment profile characterized by short-term optimism overshadowed by a weak long-term outlook. The stock's recent 2.87% daily decline, underperforming the broader market, belies a prior-period gain of 8.16%. The core tension lies in its upcoming earnings, where a projected 219.23% year-over-year surge in quarterly EPS to $0.31 on stable revenue of $42.96 million is directly contradicted by the full-year forecast. Consensus estimates for the full year anticipate a significant 37.42% contraction in EPS and a 0.73% decline in revenue. This negative trajectory is reinforced by a Zacks Rank of #4 (Sell) and stagnant analyst EPS revisions over the past 30 days, indicating a lack of positive catalysts. While the company's forward P/E ratio of 6.5 appears attractive, representing a deep discount to the industry average of 31.31, it likely reflects the market pricing in the substantial risks highlighted by the poor full-year guidance rather than indicating a clear value opportunity.

Key Decisions for Investors

• Investors should weigh the anticipated 219.23% YoY quarterly EPS surge against the negative full-year forecast, which projects a 37.42% earnings decline, to determine if the short-term strength justifies the long-term risk.
• Treat the low forward P/E of 6.5 with caution, as the 'Sell' rating and stagnant analyst estimates suggest it may be a value trap reflecting significant business risks rather than a compelling entry point.
• Scrutinize the upcoming earnings report and management commentary for any revisions to the full-year outlook, as this will be more indicative of the company's fundamental health than the anomalous quarterly EPS growth.